欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/0762/001
药品名称Rapydan
活性成分
    • Lidocaine 70.0 mg
    • Tetracaine 70.0 mg
剂型Medicated plaster
上市许可持有人Eurocept International B.V, the Netherlands
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Cyprus (CY)
      RAPYDAN 70MG/70MG/MEDICATED PLASTER
    • Germany (DE)
      Rapydan 70 mg/70 mg medizinisches Pflaster
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
      Rapydan pleister 70/70 mg
    • Luxembourg (LU)
    • Ireland (IE)
    • Austria (AT)
      Rapydan 70mg/70 mg wirkstoffhaltiges Pflaster
    • Portugal (PT)
    • Greece (GR)
    • Norway (NO)
    • Poland (PL)
    • Hungary (HU)
      Velocain 70/70 mg gyógyszeres tapasz
许可日期2007/10/10
最近更新日期2025/01/20
药物ATC编码
    • N01BB52 lidocaine, combinations
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase